ZIMMER BIOMET HOLDINGS, INC. (ZBH) Risk Factors
Health CareLatest 10-K filed Feb 20, 2026Source: SEC EDGAR
WealthWire extracted and classified 34 risk factors from ZIMMER BIOMET HOLDINGS, INC.’s latest SEC filing, mapping each to a standardized risk taxonomy so they can be compared across every company and sector. The breakdown below shows how those disclosures distribute across risk categories.
Financial
9 factorsLegal & regulatory
8 factorsMarket & business
5 factorsTechnology
4 factorsOperations & people
4 factorsESG & reputation
2 factorsHealthcare & life sciences
1 factorsOther
1 factorsRecent key developments
Concrete developments — dated events, named agreements and instruments, legal proceedings — that ZIMMER BIOMET HOLDINGS, INC. surfaced in its latest filing.
- Interruptions from enterprise resource planning system implementation negatively impacted product distribution in 2024, particularly an Americas ERP transition disrupting customer order fulfillment in the second half of fiscal 2024.2024
- One sterilization supplier experienced bankruptcy or other financial constraints in 2024.2024
- Existing litigation related to the change in go-to-market strategy in impacted markets, with potential for additional litigation.
- Total indebtedness at December 31, 2025 was $7.5 billion, with $0.6 billion in principal debt service obligations over next 12 months.December 31, 2025
- China implemented volume-based procurement processes that reduced margins and required renegotiation of distributor arrangements.
- Italian Pay Back law requiring reimbursement to government from medical device industry since 2015.2015
- Italian Fund for the Government of Medical Devices applicable to revenues from medical devices, large equipment, and IVDs since 2024.2024
- OECD Pillar 2 framework implementing a global minimum corporate tax of 15% for large companies; certain countries adopted legislation; OECD issued new administrative guidance on January 5, 2026.January 5, 2026
- Divestiture of retained ZimVie common stock completed in February 2023.February 2023
- Spinoff tax-free status relies on IRS rulings and opinion; potential substantial tax liability if not qualified.
- Attacks on shipping transiting the Red Sea caused increased shipping costs and transit delays.
- U.S. tariff and export controls policies experienced rapid change, with retaliatory tariffs adversely affecting cost of goods sold and revenue.
- Product liability lawsuits and claims related to various products are currently defended.
- Lawsuits challenging characterization of independent agents and distributors as contractors, potentially requiring withholding and benefit provisions with liability for unpaid past taxes.
Go deeper on ZBH
This page shows the category breakdown of the latest filing. The WealthWire API and dashboard add the full risk-factor text, multi-year trends, sector comparisons, and CSV export — for ZBH and every other S&P 500 company.